Haemonetics Corporation‘s (HAE) MACD indicator has entered into bearish territory with a reading of -0.1380. The Zacks #4 Rank (“Sell”) stock decreased more than 2% to $58.44 in morning trade. The Zacks Consensus Estimate for the year ending March 2012 has decreased by 29 cents over the past month to $3.09 per share.
Stocks
